Question 1

What are the main strengths of investing in ZTS?

Accepted Answer

The main strengths of investing in Zoetis Inc. include: 80.6% renewable electricity with 26.7% Scope 1&2 emissions reduction, $11.3M foundation grants supporting veterinary education and animal welfare, First animal health company with comprehensive ESG reporting framework.

Question 2

What are the potential drawbacks of investing in ZTS?

Accepted Answer

Potential drawbacks of investing in Zoetis Inc. include: Pharmaceutical development inherently requires animal testing protocols, Antibiotic products face regulatory scrutiny over resistance concerns, Limited ESG rating transparency from major agencies like MSCI/Sustainalytics.

Question 3

What are the key financial metrics for ZTS?

Accepted Answer

Key financial metrics for Zoetis Inc. include: Market Cap: $1.48 billion, Current Price: $39.97, Dividend Yield: 1.22%.

Zoetis Inc.

Detailed View

ZTS

ESG Ratings